Jointly sponsored/co-provided by Postgraduate Institute for Medicine and MedEdicus LLC
Supported by an educational grant from Allergan, Inc, and Astellas Pharma US Inc.
Specialty: Women's Health
Release date: December 31, 2013
Valid through: January 31, 2015
Overactive bladder (OAB) is a common condition affecting millions of American women, resulting in an adverse impact on numerous quality-of-life measures. This syndrome is easy to identify and can be effectively managed with available therapies, which include new options for both recently diagnosed and treatment-refractory patients. However, for a number of reasons, OAB is widely underdiagnosed and undertreated. Application of appropriate methods to elicit information from patients on bladder voiding issues, development of approaches for efficient diagnosis and counseling, and informed discussion of current treatment modalities and referral considerations could help to overcome many of the existing barriers to the recognition and care of women with OAB. Based on this idea, a multidisciplinary panel of physicians with expert knowledge of OAB convened to discuss OAB screening, diagnostic evaluation, and clinical management. It is hoped the contents of this program will lead to increased recognition of OAB and optimization of treatment delivery.